| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 09/09/1998 | EP0651641B1 Novel bioactive compositions, preparation and use thereof |
| 09/09/1998 | CN1192739A N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists |
| 09/09/1998 | CN1192729A Benzamide derivatives and their use as vasopressin antagonists |
| 09/09/1998 | CN1039714C Substituted indole derivatives, prepn. method and application thereof |
| 09/08/1998 | US5804599 Oxabicyclo(4.1.0)heptane derivatives; antibacterial agents |
| 09/08/1998 | US5804554 Calcium channel blocking polypeptides from filistata hibernalis |
| 09/08/1998 | US5804419 Encoded by a polynucleotide sequence; forming hybridization complex with nucleic acid material of sample; detecting complex. |
| 09/03/1998 | WO1998037889A1 Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, motion sickness and vertigo |
| 09/03/1998 | CA2282396A1 Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, motion sickness and vertigo |
| 09/02/1998 | EP0861896A2 Cell volume regulated human kinase h-sgk |
| 09/02/1998 | EP0861260A1 Improved method and agents for inhibiting protein aging |
| 09/02/1998 | EP0861238A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| 09/02/1998 | EP0861235A1 Substituted benzylaminopiperidine compounds |
| 09/02/1998 | CN1192219A Reversible cysteine protease inhibitors |
| 09/01/1998 | USRE35886 Endothelin-converting enzyme inhibitor |
| 09/01/1998 | US5801170 Heterocyclic biphenylylamides useful as 5HT1D antagonists |
| 08/27/1998 | WO1998036747A1 Pharmaceutical composition |
| 08/26/1998 | EP0860506A1 Human protein kinase hYAKI (HOACF 72) |
| 08/26/1998 | EP0860502A1 cDNA clone HDPBI30 that encodes a novel human 7-transmembrane receptor |
| 08/26/1998 | EP0859787A1 G-protein coupled receptor hnfds78 |
| 08/26/1998 | EP0859762A1 Cytokine production inhibitors, formulations thereof and their use in medicine, and methods for their identification |
| 08/26/1998 | EP0859621A1 Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis |
| 08/26/1998 | EP0767787B1 (3,4-dioxocyclobuten-1-yl)chromene, indene, and dihydronaphthalenone derivatives as smooth muscle relaxants |
| 08/26/1998 | CN1191543A Meiosis regulating compounds |
| 08/26/1998 | CN1191533A 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivs. as neurokinin receptor antagonists |
| 08/26/1998 | CN1191491A 结缔组织生长因子 Connective tissue growth factor |
| 08/26/1998 | CN1191484A Melatonin agonists for treating benign prostatic hyperplasia |
| 08/26/1998 | CN1191139A Liquid gonadotropin containing formulations |
| 08/25/1998 | US5798389 Administering docosahexaenoic acid and it's derivative for treating autoimmune disease, kidney disorder and side effect reduction |
| 08/25/1998 | US5798373 Tri-substituted phenyl derivatives useful as PDE IV inhibitors |
| 08/25/1998 | US5798362 Useful as alpha-adrenoreceptor blockers; condensation |
| 08/25/1998 | US5798357 Thromboxane synthetase inhibitors |
| 08/25/1998 | CA2224111A1 Novel compounds |
| 08/24/1998 | CA2220855A1 Cdna clone hdpb130 that encodes a novel human 7-transmembrane receptor |
| 08/20/1998 | WO1998035963A1 Process for preparing eprosartan |
| 08/20/1998 | WO1998035962A1 Process for preparing eprosartan |
| 08/20/1998 | WO1998014596A3 Disease associated protein tyrosine phosphatases |
| 08/19/1998 | EP0859054A1 Drug binding protein |
| 08/19/1998 | EP0858338A1 Pharmaceutical compositions of levo-enantiomers of medetomidine derivatives and their use |
| 08/19/1998 | EP0858337A2 A pharmaceutical composition for the treatment of autoimmune diseases |
| 08/19/1998 | CN1190967A Heterocyclylcarboxamide derivatives and their use as therapeutic agents |
| 08/19/1998 | CN1190896A Stabilized pharmaceutical formulation comprising a growth hormone and a peptide comprising at least, one basic amino acid residue and at least one acid amino acid residue |
| 08/19/1998 | CN1190888A Methods and compositions for inhibiting 5 'alpha'=reductase activity |
| 08/19/1998 | CA2223020A1 Human protein kinase hoacf72 |
| 08/18/1998 | US5795886 Anticonvulsants |
| 08/18/1998 | US5795882 Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations |
| 08/18/1998 | US5795574 Use of an extract from a non-photosynthetic filamentous bacterium and composition containing it |
| 08/18/1998 | CA2215920A1 Drug binding protein |
| 08/13/1998 | WO1998035031A1 Prostate specific regulatory nucleic acid sequences and transgenic non-human animals expressing prostate specific antigen |
| 08/13/1998 | WO1998034949A2 Monocyclic compounds with four bifunctional residues having nk-2 antagonist action |
| 08/13/1998 | WO1998034929A1 Il-8 receptor antagonists |
| 08/13/1998 | WO1998034919A1 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines |
| 08/13/1998 | WO1998011206A3 THERAPY FOR α-GALACTOSIDASE A DEFICIENCY |
| 08/13/1998 | CA2280228A1 Monocyclic compounds with four bifunctional residues having nk-2 antagonist action |
| 08/13/1998 | CA2280051A1 Prostate specific regulatory nucleic acid sequences and transgenic non-human animals expressing prostate specific antigen |
| 08/13/1998 | CA2280048A1 Il-8 receptor antagonists |
| 08/12/1998 | EP0857786A1 RNA dependent amidotransferase B from Staphylococcus Aureus |
| 08/12/1998 | EP0857785A1 RNA dependent amidotransferase C from Staphylococcus Aureus |
| 08/12/1998 | EP0857487A2 Combinations for prophylaxsis and/or treatment of benign prostatic hyperplasia containing a 17 beta-hydroxy steroid dehydrogenase (17bHSD) inhibitor and at least one further active ingredient |
| 08/12/1998 | EP0857173A1 Meiosis regulating compounds |
| 08/12/1998 | CN1190391A Tricyclic benzazepine vasopressin antagonists |
| 08/12/1998 | CN1190022A Chinese medicine capsule for nephritis |
| 08/11/1998 | US5792783 Capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation |
| 08/11/1998 | US5792772 Enatiomerically pure hydroxylated xanthine compounds |
| 08/11/1998 | US5792767 Bicyclic substituted hexahydrobenz e! isoindole alpha-1 adrenergic antagonists |
| 08/11/1998 | US5792764 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use |
| 08/11/1998 | US5792629 Nucleotide and amino acid sequences |
| 08/07/1998 | CA2222987A1 Novel compounds |
| 08/07/1998 | CA2222978A1 Novel compounds |
| 08/07/1998 | CA2222961A1 Novel compounds |
| 08/06/1998 | WO1998033780A1 Endothelin antagonists: n-[[2'-[ [(4,5-dimethyl-3-isoxazolyl) amino]sulfonyl]-4-(2-oxazolyl) [1,1'-biphenyl]-2-yl]methyl] -n,3,3-trimethylbutanamide and n-(4,5-dimethyl-3-isoxazolyl) -2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl) methyl] -4'-(2-oxazolyl)[1,1'-biphenyl]-2-sulfonamide and salts thereof |
| 08/06/1998 | WO1998033529A1 Treatment for urinary incontinence using gene therapy techniques |
| 08/06/1998 | WO1998033508A1 Calcareous material |
| 08/06/1998 | WO1998021332A3 Secreted proteins and polynucleotides encoding them |
| 08/06/1998 | CA2279594A1 Calcareous material |
| 08/06/1998 | CA2279577A1 Treatment for urinary incontinence using gene therapy techniques |
| 08/06/1998 | CA2279178A1 Endothelin antagonists: n-[[2'-[ [(4,5-dimethyl-3-isoxazolyl) amino]sulfonyl]-4-(2-oxazolyl) [1,1'-biphenyl]-2-yl]methyl] -n,3,3-trimethylbutanamide and n-(4,5-dimethyl-3-isoxazolyl) -2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl) methyl] -4'-(2-oxazolyl)[1,1'-biphenyl]-2-sulfonamide and salts thereof |
| 08/05/1998 | EP0856312A1 Use of trospium chloride for the manufacture of a medicament for the treatment of diseases of the bladder |
| 08/05/1998 | EP0856050A1 Transforming growth factor alpha hi |
| 08/05/1998 | EP0855910A1 Conjugates useful in the treatment of benign prostatic hyperplasia |
| 08/05/1998 | EP0690872B1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 08/05/1998 | EP0553263B1 1'-aminospiro-[isoquinoline-4(1h),3'-pyrrolidine]- 1,2',3,5'(2h)-tetrones and analogs thereof useful as aldose reductase inhibitors in vivo |
| 08/05/1998 | CN1189829A Piperazino derivatives as neurokinin antagonists |
| 08/05/1998 | CN1039416C Process for preparing novel pyrido (3,2-B) (1.5) benzothiazepines |
| 08/04/1998 | US5789442 Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents |
| 08/04/1998 | US5789432 Aromatase-inhibiting composition containing azole derivative |
| 08/04/1998 | US5789426 Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation |
| 08/04/1998 | US5789395 Method of using tetracycline compounds for inhibition of endogenous nitric oxide production |
| 08/04/1998 | US5788987 Time-specific controlled release dosage formulation |
| 08/04/1998 | US5788984 Gestodene-containing agent for transdermal administration |
| 08/04/1998 | US5788963 Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy |
| 07/30/1998 | WO1998032865A1 Novel prostate-associated kallikrein |
| 07/30/1998 | WO1998032766A1 SUBSTITUTED AMINO BICYCLIC-β-LACTAM PENAM AND CEPHAM DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS |
| 07/30/1998 | WO1998032438A1 Il-8 receptor antagonists |
| 07/30/1998 | WO1998032425A1 Pharmaceutical formulations with delayed drug release |
| 07/30/1998 | WO1998027108A3 New amide compounds and their use as nitric oxide synthase inhibitors |
| 07/30/1998 | WO1998021237A3 Peptide compounds useful for modulating FGF receptor activity |
| 07/30/1998 | CA2278779A1 Substituted amino bicyclic-.beta.-lactam penam and cepham derivatives as cysteine protease inhibitors |
| 07/30/1998 | CA2278623A1 Novel prostate-associated kallikrein |
| 07/30/1998 | CA2278427A1 Il-8 receptor antagonists |